Illumina (STU:ILU) Total Liabilities : €4,004 Mil (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Illumina Total Liabilities?

Illumina's Total Liabilities for the quarter that ended in Dec. 2023 was €4,004 Mil.

Illumina's quarterly Total Liabilities declined from Jun. 2023 (€4,817.14 Mil) to Sep. 2023 (€3,957.89 Mil) but then increased from Sep. 2023 (€3,957.89 Mil) to Dec. 2023 (€4,003.62 Mil).

Illumina's annual Total Liabilities increased from Dec. 2021 (€3,962.15 Mil) to Dec. 2022 (€5,336.43 Mil) but then declined from Dec. 2022 (€5,336.43 Mil) to Dec. 2023 (€4,003.62 Mil).

Illumina Total Liabilities Historical Data

The historical data trend for Illumina's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Illumina Total Liabilities Chart

Illumina Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

2,432.70

2,376.40

3,962.15

5,336.43

4,003.62

Illumina Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Liabilities	Get a 7-Day Free Trial															5,336.43	4,780.21	4,817.14	3,957.89	4,003.62

Illumina Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Illumina's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1439.69	+	(1995.392	+	568.54
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	4,004

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	9271.787	-	5268.165
	=	4,004

Illumina's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1439.69	+	(1995.392	+	568.54
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	4,004

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	9271.787	-	5268.165
	=	4,004

Illumina Total Liabilities Related Terms

Thank you for viewing the detailed overview of Illumina's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Illumina (STU:ILU) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Illumina Inc (STU:ILU) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

ILMN:USA ILMN:Mexico 1ILMN:Italy ILU:Germany ILMN:Austria

Address

5200 Illumina Way, San Diego, CA, USA, 92122

Website

https://www.illumina.com

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates about 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (about 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Illumina (STU:ILU) Headlines

No Headlines